RESTORATION OF T CELL ACTIVITY VIA THE CD39/CD73 AXIS

• 收藏
• 分享

专利权人:

INNATE PHARMA

发明人:

Stéphanie Chanteux,Nicolas Gourdin,Carine Paturel,Ivan Perrot,Benjamin Rossi

申请号：

US16370726

公开号：

US20190218308A1

申请日:

2019.03.29

申请国别(地区):

US

年份:

2019

代理人:

摘要：

The present invention relates to methods of using compounds that inhibit the enzymatic activity of soluble human CD39 to treat cancer, including but not limited to the treatment of cancers characterized by CD73 expressing cells.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/